The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the first medical device to treat patent ductus arteriosus (PDA) in premature babies weighing as little ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system enables precise ...
Chicago-based Abbott Laboratories received an FDA approval for the Amplatzer Piccolo Occluder to treat patent ductus arteriosus (PDA), a condition in which a newborn has a persistent opening in the ...
(RTTNews) - Abbott (ABT) Thursday said it has received U.S. Food and Drug Administration clearance and CE Mark approval for its Amplatzer Piccolo Delivery System, designed to treat premature babies ...
Abbott obtained US Food and Drug Administration (FDA) approval for its pea-sized Amplatzer Piccolo Occluder. This is the first medical device in the world to receive FDA approval for the treatment of ...
The healthcare company released highly encouraging data on an important pediatric device. Three years of data on the Amplatzer Piccolo Occluder show an extremely high survival rate in patients. Abbott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results